Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
86 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | TABLET | Resolved | 2019-10-31 | 2020-05-01 | 97622 |
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2019-10-31 | 2020-09-24 | 97625 |
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2019-10-31 | 2020-04-23 | 97628 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2023-07-18 | 2023-07-21 | 198957 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42591 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42594 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118925 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2022-07-25 | 2022-10-01 | 165441 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163918 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43122 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2018-08-31 | 2018-10-20 | 59704 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Actual shortage | 2025-05-08 | 2025-05-11 | 256911 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1026 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1035 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-07-27 | 2292 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144752 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-09-17 | 2020-11-19 | 124480 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-03-26 | 2020-05-14 | 109580 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
TEVA-DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
TEVA-DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
TEVA-DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
TEVA-DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
TEVA-DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |